ID DB06366 CATEGORY

Monoclonal antibodies PERTUZUMAB 148 kDa INDICATION DESCRIPTION Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain Subdomain II of the human epidermal growth factor receptor 2 protein HER2 It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively FDA approved June 8 2012

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "ID DB06366 CATEGORY" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.